Opendata, web and dolomites

ARM-B

The ARM-B skin-allergy diagnostics patch is a compact, easy to apply, low-cost allergy testing product.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 ARM-B project word cloud

Explore the words cloud of the ARM-B project. It provides you a very rough idea of what is the project "ARM-B" about.

electrical    prevalent    vivo    segments    draws    alike    severity    few    shaped    consequence    prick    company    adverse    panels    innovation    mark    register    microgel    applicable    specialist    outcomes    degree    microns    sensors    reactions    depths    pen    device    minimising    skin    consultation    provides    mm    hundred    ultra    acquires    panel    stick    tine    patients    market    allergy    biotech    alternative    engineered    collated    arm    picomole    interpreted    viz    allogen    pain    self    millimetre    solution    setting    uses    intrusive    patch    structure    patient    purified    healthcare    offers    free    data    pricks    reaction    microarray    innovating    allergen    markets    allergens    quantitative    invasiveness    nausea    ensures    nl    clinical    allergic    penetrating    diagnostics    extends    microelectrode    minutes    epidermis    risk    clinics    home    simplicity    biosensor    advantages    dataset    malaise    impedance    raining    reliability    oriented    biosensors    disc    practitioners    accredited    individual    therapist   

Project "ARM-B" data sheet

The following table provides information about the project.

Coordinator
ALLOGEN BIOTECH LIMITED 

Organization address
address: 12 SEAFIELD ROAD CLONTARF
city: DUBLIN
postcode: D03YT25
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Ireland [IE]
 Project website http://www.allogenbiotech.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-06-01   to  2018-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    ALLOGEN BIOTECH LIMITED IE (DUBLIN) coordinator 50˙000.00

Map

 Project objective

Allogen Biotech is innovating the ARM-B allergy diagnostics patch technology for use in the healthcare sector and home-test markets. The company’s advanced biosensor concept draws on the simplicity and reliability of traditional skin-prick procedures, yet provides improved clinical outcomes and patient experience. The Allogen innovation is engineered as 50 mm stick-on disc-shaped patch, composed of a microarray device, which identify panels of allergic reactions. Each type of allergic response is interpreted as electrical impedance changes at individual biosensors. The allergy specialist acquires the test results in 5 minutes on a wide panel of common or specific allergens. The sensors register the degree of severity of an allergic reaction and may provide further information on specific testing. The ARM-B system offers unique advantages for the allergy therapist and patients alike. The patch device is non-intrusive – no need to pen-mark or prick large areas of skin: ARM-B microarray extends only 30 mm. The tine-microelectrode structure of the biosensor component ensures ultra-low invasiveness, penetrating only a few hundred microns of epidermis, not millimetre skin-prick depths. Therefore the ARM-B test offers a pain free consultation. The in vivo patch uses only picomole/nL, of a purified allergen microgel, minimising the risk of adverse side effects prevalent with skin-pricks – viz. nausea, raining, malaise. The device offers a large allergy dataset, a consequence of the microarray concept. The sensors are quantitative, so data on degree of allergic response or severity is collated. The solution to skin-oriented allergy diagnostics is applicable to several alternative market segments, not only accredited clinics and general practice with specialist allergy practitioners, but also in the self-test or home-use setting. ARM-B is a high value, low-cost solution for allergy diagnostics.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ARM-B" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ARM-B" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

GREEN WHS (2019)

NATURE FRIENDLY WATER HYDRAULIC STEERING SYSTEM

Read More  

TuneFork (2018)

Mobile technology that brings personalized audio into your life

Read More  

PrasinoMed (2018)

First in the world ecological and sustainable cream for wound care, based on microalgaprasinococcus capsulatus

Read More